Literature DB >> 20395525

DNA mismatch repair deficiency in ampullary carcinoma: a morphologic and immunohistochemical study of 54 cases.

Narasimhan P Agaram1, Jinru Shia, Laura H Tang, David S Klimstra.   

Abstract

The significance of DNA mismatch repair (MMR) deficiency or microsatellite instability (MSI) in ampullary carcinomas remains to be defined. This study evaluated the MMR status in 54 consecutive ampullary adenocarcinomas by immunohistochemical and morphologic studies. All tumors were moderately (n = 49) or poorly (n = 5) differentiated, with 7 mucinous and 1 signet-ring cell type. Tumor-infiltrating lymphocytes (TILs) were noted in 36 tumors. Loss of MMR protein by immunohistochemical analysis was identified in 3 (6%), 2 lost MSH6, and 1 lost MLH1/PMS2. One MSH6- case had 3 metachronous colorectal cancers. Five TILs per 10 high-power fields predicted immunohistochemical abnormality in 2 of 3 tumors with a specificity of 80% (41/51); however, none of the 5 tumors that had the highest TIL counts (20-62/10 high-power fields) showed abnormal immunohistochemical results. Thus, MMR deficiency occurs in ampullary carcinoma but appears less frequent than in colorectal carcinoma (CRC). Typical MSI-high histologic features of CRC, such as increased TIL counts, seem to have similar yet subtly different implications in ampullary carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20395525     DOI: 10.1309/AJCPGDDE8PLLDRCC

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  17 in total

1.  Ampullary cancer: Evaluation of somatic and germline genetic alterations and association with clinical outcomes.

Authors:  Winston Wong; Maeve A Lowery; Michael F Berger; Yelena Kemel; Barry Taylor; Ahmet Zehir; Preethi Srinivasan; Chaitanya Bandlamudi; Joanne Chou; Marinela Capanu; Anna Varghese; Kenneth H Yu; Christine A Iacobuzio-Donahue; Jinru Shia; David S Klimstra; William R Jarnagin; Zsofia K Stadler; Eileen M O'Reilly
Journal:  Cancer       Date:  2019-01-08       Impact factor: 6.860

Review 2.  Lynch syndrome-associated neoplasms: a discussion on histopathology and immunohistochemistry.

Authors:  Jinru Shia; Susanne Holck; Giovanni Depetris; Joel K Greenson; David S Klimstra
Journal:  Fam Cancer       Date:  2013-06       Impact factor: 2.375

3.  Clinical, morphologic, and immunophenotypic characteristics of ampullary carcinomas with an emphasis on SMAD4 expression.

Authors:  Ahmad Alkhasawneh; Lizette Vila Duckworth; Thomas J George; Neelam V Desai; Alex J Sommerfeld; Xiaomin Lu; Tania Zuluaga Toro
Journal:  J Gastrointest Oncol       Date:  2016-12

4.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency.

Authors:  Dung T Le; Jennifer N Uram; Hao Wang; Bjarne R Bartlett; Holly Kemberling; Aleksandra D Eyring; Andrew D Skora; Brandon S Luber; Nilofer S Azad; Dan Laheru; Barbara Biedrzycki; Ross C Donehower; Atif Zaheer; George A Fisher; Todd S Crocenzi; James J Lee; Steven M Duffy; Richard M Goldberg; Albert de la Chapelle; Minori Koshiji; Feriyl Bhaijee; Thomas Huebner; Ralph H Hruban; Laura D Wood; Nathan Cuka; Drew M Pardoll; Nickolas Papadopoulos; Kenneth W Kinzler; Shibin Zhou; Toby C Cornish; Janis M Taube; Robert A Anders; James R Eshleman; Bert Vogelstein; Luis A Diaz
Journal:  N Engl J Med       Date:  2015-05-30       Impact factor: 91.245

5.  Sporadic duodenal adenoma and association with colorectal neoplasia: a case-control study.

Authors:  Reem Z Sharaiha; Michelle S Cohen; Laura Reimers; Mouen A Khashab; Francis M Giardiello; Alfred I Neugut
Journal:  Dig Dis Sci       Date:  2014-05-13       Impact factor: 3.199

Review 6.  Systematic evaluation of immune regulation and modulation.

Authors:  David F Stroncek; Lisa H Butterfield; Michael A Cannarile; Madhav V Dhodapkar; Tim F Greten; Jean Charles Grivel; David R Kaufman; Heidi H Kong; Firouzeh Korangy; Peter P Lee; Francesco Marincola; Sergio Rutella; Janet C Siebert; Giorgio Trinchieri; Barbara Seliger
Journal:  J Immunother Cancer       Date:  2017-03-21       Impact factor: 13.751

7.  New therapeutic targets for pulmonary sarcomatoid carcinomas based on their genomic and phylogenetic profiles.

Authors:  Takahiro Nakagomi; Taichiro Goto; Yosuke Hirotsu; Daichi Shikata; Yujiro Yokoyama; Rumi Higuchi; Kenji Amemiya; Kenichiro Okimoto; Toshio Oyama; Hitoshi Mochizuki; Masao Omata
Journal:  Oncotarget       Date:  2018-01-31

Review 8.  Microsatellite instability in gastric cancer: molecular bases, clinical perspectives, and new treatment approaches.

Authors:  Margherita Ratti; Andrea Lampis; Jens C Hahne; Rodolfo Passalacqua; Nicola Valeri
Journal:  Cell Mol Life Sci       Date:  2018-09-01       Impact factor: 9.261

Review 9.  Hypermutation and microsatellite instability in gastrointestinal cancers.

Authors:  Kizuki Yuza; Masayuki Nagahashi; Satoshi Watanabe; Kazuaki Takabe; Toshifumi Wakai
Journal:  Oncotarget       Date:  2017-12-01

Review 10.  Understanding Intratumor Heterogeneity and Evolution in NSCLC and Potential New Therapeutic Approach.

Authors:  Taichiro Goto; Yosuke Hirotsu; Kenji Amemiya; Hitoshi Mochizuki; Masao Omata
Journal:  Cancers (Basel)       Date:  2018-06-22       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.